An Verrijken
Overview
Explore the profile of An Verrijken including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1914
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Dijck E, Diels S, Fransen E, Cremers T, Verrijken A, Dirinck E, et al.
Antioxidants (Basel)
. 2024 Sep;
13(9).
PMID: 39334710
The paraoxonase () gene family (including PON1, PON2, and PON3), is known for its anti-oxidative and anti-inflammatory properties, protecting against metabolic diseases such as obesity and metabolic dysfunction-associated steatotic liver...
2.
Peleman C, Hellemans S, Veeckmans G, Arras W, Zheng H, Koeken I, et al.
Cell Death Differ
. 2024 Jul;
31(9):1113-1126.
PMID: 39060422
There is an unmet clinical need for pharmacologic treatment for metabolic dysfunction-associated steatotic liver disease (MASLD). Hepatocyte cell death is a hallmark of this highly prevalent chronic liver disease, but...
3.
van Kleef L, Francque S, Prieto-Ortiz J, Sonneveld M, Sanchez-Luque C, Prieto-Ortiz R, et al.
Gastroenterology
. 2024 Mar;
167(2):357-367.e9.
PMID: 38513745
Background & Aims: There is an unmet need for noninvasive tests to improve case-finding and aid primary care professionals in referring patients at high risk of liver disease. Methods: A...
4.
Van Dessel K, Verrijken A, De Block C, Verhaegen A, Peiffer F, Van Gaal L, et al.
Clin Nutr ESPEN
. 2024 Jan;
59:422-435.
PMID: 38220405
Background & Aims: Weight reduction programs in people with overweight or obesity can be informed by indirect calorimetry (IC) which is the gold standard to measure basal metabolic rate (BMR)....
5.
Clavreul L, Bernard L, Cotte A, Hennuyer N, Bourouh C, Devos C, et al.
Metabolism
. 2023 Nov;
151:155720.
PMID: 37926201
Background And Aims: Peroxisome Proliferator-Activated Receptor α (PPARα) is a key regulator of hepatic lipid metabolism and therefore a promising therapeutic target against Metabolic-dysfunction Associated Steatotic Liver Diseases (MASLD). However,...
6.
De Herdt C, De Block C, Francque S, Verrijken A, Van Dessel K, Van Gaal L, et al.
Endocrine
. 2023 Mar;
80(1):54-63.
PMID: 36857008
Purpose: To study the association between testosterone and non-alcoholic fatty liver disease (NAFLD) since prior studies have reported inconsistent results. Methods: A retrospective analysis was performed including obese men who...
7.
Van Dijck E, Beckers S, Diels S, Huybrechts T, Verrijken A, Van Hoorenbeeck K, et al.
Genes (Basel)
. 2022 Oct;
13(10).
PMID: 36292633
Recently, it was reported that heterozygous PCSK1 variants, causing partial PC1/3 deficiency, result in a significant increased risk for obesity. This effect was almost exclusively generated by the rare p.Y181H...
8.
Meijnikman A, Davids M, Herrema H, Aydin O, Tremaroli V, Rios-Morales M, et al.
Nat Med
. 2022 Oct;
28(10):2100-2106.
PMID: 36216942
To test the hypothesis that the gut microbiota of individuals with nonalcoholic fatty liver disease (NAFLD) produce enough ethanol to be a driving force in the development and progression of...
9.
Deprince A, Hennuyer N, Kooijman S, Pronk A, Bauge E, Lienard V, et al.
Hepatology
. 2022 Jun;
77(4):1287-1302.
PMID: 35735979
Background: NAFLD affects nearly 25% of the global population. Cardiovascular disease (CVD) is the most common cause of death among patients with NAFLD, in line with highly prevalent dyslipidemia in...
10.
Zanoni P, Panteloglou G, Othman A, Haas J, Meier R, Rimbert A, et al.
Circ Res
. 2021 Nov;
130(1):80-95.
PMID: 34809444
Background: The LDLR (low-density lipoprotein receptor) in the liver is the major determinant of LDL-cholesterol levels in human plasma. The discovery of genes that regulate the activity of LDLR helps...